{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T10:49:05Z","timestamp":1740134945343,"version":"3.37.3"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,3,3]],"date-time":"2023-03-03T00:00:00Z","timestamp":1677801600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,3,3]],"date-time":"2023-03-03T00:00:00Z","timestamp":1677801600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004621","name":"Kerman University of Medical Sciences","doi-asserted-by":"publisher","award":["98001230"],"award-info":[{"award-number":["98001230"]}],"id":[{"id":"10.13039\/501100004621","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurosci"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Introduction<\/jats:title>\n                <jats:p>Although ataxia is associated with cerebellar dysfunction, little is known about the effects of 3-AP exposure on Purkinje cell electrophysiological properties. Here, we evaluated these parameters in cerebellar vermis brain slices.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Purkinje cells were exposed to artificial cerebrospinal\u00a0fluid (aCSF) (control) or to 1\u00a0mM 3-acetylpyridine (3-AP) in the recording chamber. The effects of a cannabinoid agonist (WIN; 7.5\u00a0nmol) and a cannabinoid antagonist (AM; 20\u00a0nmol) were evaluated under both conditions.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Exposure to 3-AP induced dramatic changes in cellular excitability that likely would affect Purkinje cell output. In whole-cell current clamp recordings, 3-AP-exposed Purkinje cells demonstrated a significantly higher frequency of action potentials, a larger afterhyperpolarization (AHP), and a larger rebound of action potentials. In addition, 3-AP caused a significant decrease in the interspike interval (ISI), half-width, and first spike latency. Remarkably, the action potential frequency, AHP amplitude, rebound, ISI, action potential halfwidth, and first spike latency were no longer different from controls in 3-AP cells treated with AM. Sag percentage, on the other hand, showed no significant difference under any treatment condition, indicating that cannabinoids' actions on 3-AP-mediated Purkinje cell changes may not include effects on neuronal excitability through changes of Ih.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>These data show that cannabinoid antagonists reduce the excitability of Purkinje cells following exposure to 3-AP and suggest their potential as therapeutics in cerebellar dysfunctions.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12868-023-00786-4","type":"journal-article","created":{"date-parts":[[2023,3,3]],"date-time":"2023-03-03T15:02:39Z","timestamp":1677855759000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Pharmacologic antagonism of CB1 receptors improves electrophysiological alterations in Purkinje cells exposed to 3-AP"],"prefix":"10.1186","volume":"24","author":[{"given":"Hoda","family":"Ranjbar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monavareh","family":"Soti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristi A.","family":"Kohlmeier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahyar","family":"Janahmadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad","family":"Shabani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,3,3]]},"reference":[{"issue":"4","key":"786_CR1","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1111\/ene.12350","volume":"21","author":"M Rossi","year":"2014","unstructured":"Rossi M, Perez-Lloret S, Doldan L, Cerquetti D, Balej J, Millar Vernetti P, et al. Autosomal dominant cerebellar ataxias: a systematic review of clinical features. Eur J Neurol. 2014;21(4):607\u201315. https:\/\/doi.org\/10.1111\/ene.12350.","journal-title":"Eur J Neurol"},{"issue":"4","key":"786_CR2","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1097\/WCO.0b013e32834875ba","volume":"24","author":"T Klockgether","year":"2011","unstructured":"Klockgether T. Update on degenerative ataxias. Curr Opin Neurol. 2011;24(4):339\u201345. https:\/\/doi.org\/10.1097\/WCO.0b013e32834875ba.","journal-title":"Curr Opin Neurol"},{"key":"786_CR3","doi-asserted-by":"publisher","first-page":"94","DOI":"10.3389\/fnmol.2019.00094","volume":"12","author":"M G\u00f3mez-Ruiz","year":"2019","unstructured":"G\u00f3mez-Ruiz M, Rodr\u00edguez-Cueto C, Luna-Pi\u00f1el E, Hern\u00e1ndez-G\u00e1lvez M, Fern\u00e1ndez-Ruiz J. Endocannabinoid system in spinocerebellar ataxia type-3 and other autosomal-dominant cerebellar ataxias: potential role in pathogenesis and expected relevance as neuroprotective targets. Front Mol Neurosci. 2019;12:94. https:\/\/doi.org\/10.3389\/fnmol.2019.00094.","journal-title":"Front Mol Neurosci"},{"issue":"3","key":"786_CR4","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1177\/1073858404263517","volume":"10","author":"SM Morton","year":"2004","unstructured":"Morton SM, Bastian AJ. Cerebellar control of balance and locomotion. Neurosci Review J Bringing Neurobiol Neurol Psychiatry. 2004;10(3):247\u201359. https:\/\/doi.org\/10.1177\/1073858404263517.","journal-title":"Neurosci Review J Bringing Neurobiol Neurol Psychiatry"},{"issue":"9","key":"786_CR5","doi-asserted-by":"publisher","first-page":"2339","DOI":"10.1007\/s00221-022-06415-6","volume":"240","author":"H Ranjbar","year":"2022","unstructured":"Ranjbar H, Soti M, Janahmadi M, Kohlmeier KA, Sheibani V, Ahmadi-Zeidabadi M, et al. Modulation of the CB1 cannabinoid receptor has potential therapeutic utility in the 3-acetylpyridine cerebellar ataxia rat model. Exp Brain Res. 2022;240(9):2339\u201348. https:\/\/doi.org\/10.1007\/s00221-022-06415-6.","journal-title":"Exp Brain Res"},{"key":"786_CR6","doi-asserted-by":"publisher","DOI":"10.1080\/00207454.2022.2126771","author":"H Ranjbar","year":"2022","unstructured":"Ranjbar H, Soti M, Kohlmeier KA, Sheibani V, Ahmadi-Zeidabadi M, Rafiepour K, et al. The cannabinoid antagonist, AM251 attenuates ataxia related deficiencies in a cerebellar ataxic model. Int J Neurosci. 2022. https:\/\/doi.org\/10.1080\/00207454.2022.2126771.","journal-title":"Int J Neurosci"},{"key":"786_CR7","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.nbd.2016.01.009","volume":"88","author":"CJ Smeets","year":"2016","unstructured":"Smeets CJ, Verbeek DS. Climbing fibers in spinocerebellar ataxia: a mechanism for the loss of motor control. Neurobiol Dis. 2016;88:96\u2013106. https:\/\/doi.org\/10.1016\/j.nbd.2016.01.009.","journal-title":"Neurobiol Dis"},{"issue":"4","key":"786_CR8","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1016\/j.conb.2011.05.025","volume":"21","author":"JF Medina","year":"2011","unstructured":"Medina JF. The multiple roles of Purkinje cells in sensori-motor calibration: to predict, teach and command. Curr Opin Neurobiol. 2011;21(4):616\u201322. https:\/\/doi.org\/10.1016\/j.conb.2011.05.025.","journal-title":"Curr Opin Neurobiol"},{"issue":"6","key":"786_CR9","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1016\/j.neuron.2010.08.022","volume":"67","author":"L Duvick","year":"2010","unstructured":"Duvick L, Barnes J, Ebner B, Agrawal S, Andresen M, Lim J, et al. SCA1-like disease in mice expressing wild-type ataxin-1 with a serine to aspartic acid replacement at residue 776. Neuron. 2010;67(6):929\u201335. https:\/\/doi.org\/10.1016\/j.neuron.2010.08.022.","journal-title":"Neuron"},{"key":"786_CR10","doi-asserted-by":"publisher","first-page":"187","DOI":"10.3389\/fnins.2020.00187","volume":"14","author":"BB Cao","year":"2020","unstructured":"Cao BB, Zhang XX, Du CY, Liu Z, Qiu YH, Peng YP. TGF-\u03b21 provides neuroprotection via inhibition of microglial activation in 3-acetylpyridine-induced cerebellar ataxia model rats. Front Neurosci. 2020;14:187. https:\/\/doi.org\/10.3389\/fnins.2020.00187.","journal-title":"Front Neurosci"},{"issue":"Suppl 1","key":"786_CR11","first-page":"S7","volume":"32","author":"VM Saito","year":"2010","unstructured":"Saito VM, Wotjak CT, Moreira FA. Pharmacological exploitation of the endocannabinoid system: new perspectives for the treatment of depression and anxiety disorders? Revista Brasileira de Psiquiatria. 2010;32(Suppl 1):S7-14.","journal-title":"Revista Brasileira de Psiquiatria"},{"issue":"1\u20132","key":"786_CR12","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/s0091-3057(01)00539-1","volume":"69","author":"KP DeSanty","year":"2001","unstructured":"DeSanty KP, Dar MS. Cannabinoid-induced motor incoordination through the cerebellar CB(1) receptor in mice. Pharmacol Biochem Behav. 2001;69(1\u20132):251\u20139. https:\/\/doi.org\/10.1016\/s0091-3057(01)00539-1.","journal-title":"Pharmacol Biochem Behav"},{"issue":"6","key":"786_CR13","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.1111\/bph.12283","volume":"171","author":"C Rodr\u00edguez-Cueto","year":"2014","unstructured":"Rodr\u00edguez-Cueto C, Benito C, Fern\u00e1ndez-Ruiz J, Romero J, Hern\u00e1ndez-G\u00e1lvez M, G\u00f3mez-Ruiz M. Changes in CB(1) and CB(2) receptors in the post-mortem cerebellum of humans affected by spinocerebellar ataxias. Br J Pharmacol. 2014;171(6):1472\u201389. https:\/\/doi.org\/10.1111\/bph.12283.","journal-title":"Br J Pharmacol"},{"issue":"16","key":"786_CR14","doi-asserted-by":"publisher","first-page":"3919","DOI":"10.1113\/jphysiol.2012.244947","volume":"591","author":"X Wang","year":"2013","unstructured":"Wang X, Whalley BJ, Stephens GJ. The du(2J) mouse model of ataxia and absence epilepsy has deficient cannabinoid CB1 receptor-mediated signalling. J Physiol. 2013;591(16):3919\u201333. https:\/\/doi.org\/10.1113\/jphysiol.2012.244947.","journal-title":"J Physiol"},{"issue":"16","key":"786_CR15","doi-asserted-by":"publisher","first-page":"4631","DOI":"10.1113\/jp271106","volume":"594","author":"GJ Stephens","year":"2016","unstructured":"Stephens GJ. Does modulation of the endocannabinoid system have potential therapeutic utility in cerebellar ataxia? J Physiol. 2016;594(16):4631\u201341. https:\/\/doi.org\/10.1113\/jp271106.","journal-title":"J Physiol"},{"issue":"1","key":"786_CR16","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1038\/nrn3876","volume":"16","author":"V Di Marzo","year":"2015","unstructured":"Di Marzo V, Stella N, Zimmer A. Endocannabinoid signalling and the deteriorating brain. Nat Rev Neurosci. 2015;16(1):30\u201342. https:\/\/doi.org\/10.1038\/nrn3876.","journal-title":"Nat Rev Neurosci"},{"key":"786_CR17","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.neuroscience.2016.09.046","volume":"339","author":"C Rodr\u00edguez-Cueto","year":"2016","unstructured":"Rodr\u00edguez-Cueto C, Hern\u00e1ndez-G\u00e1lvez M, Hillard CJ, Maciel P, Garc\u00eda-Garc\u00eda L, Valdeolivas S, et al. Dysregulation of the endocannabinoid signaling system in the cerebellum and brainstem in a transgenic mouse model of spinocerebellar ataxia type-3. Neuroscience. 2016;339:191\u2013209. https:\/\/doi.org\/10.1016\/j.neuroscience.2016.09.046.","journal-title":"Neuroscience"},{"key":"786_CR18","doi-asserted-by":"publisher","first-page":"104860","DOI":"10.1016\/j.neubiorev.2022.104860","volume":"141","author":"H Ranjbar","year":"2022","unstructured":"Ranjbar H, Soti M, Razavinasab M, Kohlmeier KA, Shabani M. The neglected role of endocannabinoid actions at TRPC channels in ataxia. Neurosci Biobehav Rev. 2022;141:104860. https:\/\/doi.org\/10.1016\/j.neubiorev.2022.104860.","journal-title":"Neurosci Biobehav Rev"},{"key":"786_CR19","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.brainres.2017.12.013","volume":"1680","author":"T Zheng","year":"2018","unstructured":"Zheng T, Zhang R, Zhang T, Zhang M-N, Xu B, Song J-j, et al. CB1 cannabinoid receptor agonist mouse VD-hemopressin (\u03b1) produced supraspinal analgesic activity in the preclinical models of pain. Brain Res. 2018;1680:155\u201364.","journal-title":"Brain Res"},{"issue":"3","key":"786_CR20","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1016\/s0306-4522(97)00181-4","volume":"81","author":"U W\u00fcllner","year":"1997","unstructured":"W\u00fcllner U, Weller M, Groscurth P, L\u00f6schmann PA, Schulz JB, M\u00fcller I, et al. Evidence for an active type of cell death with ultrastructural features distinct from apoptosis: the effects of 3-acetylpyridine neurotoxicity. Neuroscience. 1997;81(3):721\u201334. https:\/\/doi.org\/10.1016\/s0306-4522(97)00181-4.","journal-title":"Neuroscience"},{"key":"786_CR21","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.neuroscience.2010.10.031","volume":"172","author":"M Shabani","year":"2011","unstructured":"Shabani M, Hosseinmardi N, Haghani M, Shaibani V, Janahmadi M. Maternal exposure to the CB1 cannabinoid agonist WIN 55212\u20132 produces robust changes in motor function and intrinsic electrophysiological properties of cerebellar Purkinje neurons in rat offspring. Neuroscience. 2011;172:139\u201352. https:\/\/doi.org\/10.1016\/j.neuroscience.2010.10.031.","journal-title":"Neuroscience"},{"issue":"3\u20134","key":"786_CR22","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1159\/000338494","volume":"29","author":"M Haghani","year":"2012","unstructured":"Haghani M, Shabani M, Javan M, Motamedi F, Janahmadi M. CB1 cannabinoid receptor activation rescues amyloid \u03b2-induced alterations in behaviour and intrinsic electrophysiological properties of rat hippocampal CA1 pyramidal neurones. Cell Physiol Biochem. 2012;29(3\u20134):391\u2013406.","journal-title":"Cell Physiol Biochem"},{"issue":"4","key":"786_CR23","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/S0028-3908(02)00157-0","volume":"43","author":"N Hajos","year":"2002","unstructured":"Hajos N, Freund T. Pharmacological separation of cannabinoid sensitive receptors on hippocampal excitatory and inhibitory fibers. Neuropharmacology. 2002;43(4):503\u201310.","journal-title":"Neuropharmacology"},{"key":"786_CR24","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1113\/jphysiol.1980.sp013357","volume":"305","author":"R Llin\u00e1s","year":"1980","unstructured":"Llin\u00e1s R, Sugimori M. Electrophysiological properties of in vitro Purkinje cell somata in mammalian cerebellar slices. J Physiol. 1980;305:171\u201395. https:\/\/doi.org\/10.1113\/jphysiol.1980.sp013357.","journal-title":"J Physiol"},{"issue":"5","key":"786_CR25","doi-asserted-by":"publisher","first-page":"1690","DOI":"10.1523\/JNEUROSCI.22-05-01690.2002","volume":"22","author":"T Yoshida","year":"2002","unstructured":"Yoshida T, Hashimoto K, Zimmer A, Maejima T, Araishi K, Kano M. The cannabinoid CB1 receptor mediates retrograde signals for depolarization-induced suppression of inhibition in cerebellar Purkinje cells. J Neurosci. 2002;22(5):1690\u20137. https:\/\/doi.org\/10.1523\/JNEUROSCI.22-05-01690.2002.","journal-title":"J Neurosci"},{"issue":"32","key":"786_CR26","doi-asserted-by":"publisher","first-page":"6133","DOI":"10.1523\/jneurosci.1931-19.2020","volume":"40","author":"JL Barnes","year":"2020","unstructured":"Barnes JL, Mohr C, Ritchey CR, Erikson CM, Shiina H, Rossi DJ. Developmentally transient CB1Rs on cerebellar afferents suppress afferent input, downstream synaptic excitation, and signaling to migrating neurons. J Neurosci. 2020;40(32):6133\u201345. https:\/\/doi.org\/10.1523\/jneurosci.1931-19.2020.","journal-title":"J Neurosci"},{"key":"786_CR27","doi-asserted-by":"publisher","DOI":"10.1523\/eneuro.0401-21.2021","author":"N Fourcaud-Trocm\u00e9","year":"2022","unstructured":"Fourcaud-Trocm\u00e9 N, Zbili M, Duchamp-Viret P, Kuczewski N. Afterhyperpolarization Promotes the Firing of Mitral Cells through a Voltage-Dependent Modification of Action Potential Threshold. eNeuro. 2022. https:\/\/doi.org\/10.1523\/eneuro.0401-21.2021.","journal-title":"eNeuro"},{"issue":"5","key":"786_CR28","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.1523\/JNEUROSCI.23-05-01593.2003","volume":"23","author":"RK Cloues","year":"2003","unstructured":"Cloues RK, Sather WA. Afterhyperpolarization regulates firing rate in neurons of the suprachiasmatic nucleus. J Neurosci. 2003;23(5):1593\u2013604. https:\/\/doi.org\/10.1523\/JNEUROSCI.23-05-01593.2003.","journal-title":"J Neurosci"},{"issue":"pt 1","key":"786_CR29","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1111\/j.1469-7793.1999.0201z.x","volume":"517","author":"AA Velumian","year":"1999","unstructured":"Velumian AA, Carlen PL. Differential control of three after-hyperpolarizations in rat hippocampal neurones by intracellular calcium buffering. J Physiol. 1999;517(pt 1):201\u201316. https:\/\/doi.org\/10.1111\/j.1469-7793.1999.0201z.x.","journal-title":"J Physiol"},{"issue":"18","key":"786_CR30","doi-asserted-by":"publisher","first-page":"7082","DOI":"10.1523\/JNEUROSCI.3778-14.2015","volume":"35","author":"M Hirono","year":"2015","unstructured":"Hirono M, Ogawa Y, Misono K, Zollinger DR, Trimmer JS, Rasband MN, et al. BK channels localize to the Paranodal junction and regulate action potentials in myelinated axons of cerebellar Purkinje cells. J Neurosci. 2015;35(18):7082\u201394. https:\/\/doi.org\/10.1523\/JNEUROSCI.3778-14.2015.","journal-title":"J Neurosci"},{"key":"786_CR31","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/bs.irn.2016.04.001","volume":"128","author":"C Contet","year":"2016","unstructured":"Contet C, Goulding SP, Kuljis DA, Barth AL. BK channels in the central nervous system. Int Rev Neurobiol. 2016;128:281\u2013342. https:\/\/doi.org\/10.1016\/bs.irn.2016.04.001.","journal-title":"Int Rev Neurobiol"},{"issue":"39","key":"786_CR32","doi-asserted-by":"publisher","first-page":"15154","DOI":"10.1073\/pnas.0805855105","volume":"105","author":"EA Matthews","year":"2008","unstructured":"Matthews EA, Weible AP, Shah S, Disterhoft JF. The BK-mediated fAHP is modulated by learning a hippocampus-dependent task. Proc Natl Acad Sci USA. 2008;105(39):15154\u20139. https:\/\/doi.org\/10.1073\/pnas.0805855105.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"11","key":"786_CR33","doi-asserted-by":"publisher","first-page":"6023","DOI":"10.1073\/pnas.1920008117","volume":"117","author":"X Du","year":"2020","unstructured":"Du X, Carvalho-de-Souza JL, Wei C, Carrasquel-Ursulaez W, Lorenzo Y, Gonzalez N, et al. Loss-of-function BK channel mutation causes impaired mitochondria and progressive cerebellar ataxia. Proc Natl Acad Sci USA. 2020;117(11):6023\u201334. https:\/\/doi.org\/10.1073\/pnas.1920008117.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"786_CR34","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1124\/molpharm.121.000478","volume":"102","author":"SR Srinivasan","year":"2022","unstructured":"Srinivasan SR, Huang H, Chang WC, Nasburg JA, Nguyen HM, Strassmaier T, et al. Discovery of novel activators of large-conductance calcium-activated potassium channels for the treatment of cerebellar ataxia. Mol Pharmacol. 2022;102(1):438\u201349. https:\/\/doi.org\/10.1124\/molpharm.121.000478.","journal-title":"Mol Pharmacol"},{"issue":"2","key":"786_CR35","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1111\/j.1742-7843.2004.pto940204.x","volume":"94","author":"C Liao","year":"2004","unstructured":"Liao C, Zheng J, David LS, Nicholson RA. Inhibition of voltage-sensitive sodium channels by the cannabinoid 1 receptor antagonist AM 251 in mammalian brain. Basic Clin Pharmacol Toxicol. 2004;94(2):73\u20138. https:\/\/doi.org\/10.1111\/j.1742-7843.2004.pto940204.x.","journal-title":"Basic Clin Pharmacol Toxicol"},{"issue":"1","key":"786_CR36","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1080\/19336950.2021.1910461","volume":"15","author":"Y-F Lin","year":"2021","unstructured":"Lin Y-F. Potassium channels as molecular targets of endocannabinoids. Channels. 2021;15(1):408\u201323. https:\/\/doi.org\/10.1080\/19336950.2021.1910461.","journal-title":"Channels"}],"container-title":["BMC Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12868-023-00786-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12868-023-00786-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12868-023-00786-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,3]],"date-time":"2023-03-03T15:03:27Z","timestamp":1677855807000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcneurosci.biomedcentral.com\/articles\/10.1186\/s12868-023-00786-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,3]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["786"],"URL":"https:\/\/doi.org\/10.1186\/s12868-023-00786-4","relation":{},"ISSN":["1471-2202"],"issn-type":[{"type":"electronic","value":"1471-2202"}],"subject":[],"published":{"date-parts":[[2023,3,3]]},"assertion":[{"value":"19 December 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 February 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 March 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All experiments were done in accordance with the ARRIVE guidelines and National Institutes of Health Guide for the Care and Use of Laboratory Animals) NIH Publication No. 80\u201323, revised 1996). All procedures were approved by the Research and Ethics Committee of Kerman Universities of Medical Sciences, Kerman, Iran.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval for consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"18"}}